Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-04-29

FDA Approved: SPIRIVA HANDIHALER — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Spiriva HandiHaler (tiotropium bromide) from Boehringer Ingelheim Pharmaceuticals, expanding the approved use of…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SPIRIVA HANDIHALER (TIOTROPIUM BROMIDE)

Snippet

SUPPL AP for SPIRIVA HANDIHALER (TIOTROPIUM BROMIDE)